{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:22:17Z","timestamp":1773300137547,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The D\u00fczce University coordinatorship of scientific research projects","award":["D\u00dcBAP:2020.04.03.1146"],"award-info":[{"award-number":["D\u00dcBAP:2020.04.03.1146"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92304-1","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T20:48:56Z","timestamp":1742590136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Determination of both the expression and serum levels of epidermal growth factor and transforming growth factor \u03b21 genes in COVID-19"],"prefix":"10.1038","volume":"15","author":[{"given":"Pinar","family":"Yildiz Gulhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Eroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihadiye Elif","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Yekenkurul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan Baki","family":"Altinsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ege","family":"Gulec Balbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Ercelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Davran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyma","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"92304_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2021.09.001","volume":"241","author":"JE Michalski","year":"2022","unstructured":"Michalski, J. E., Kurche, J. S. & Schwartz, D. A. From ARDS to pulmonary fibrosis: The next phase of the COVID-19 pandemic?. Transl. Res. 241, 13\u201324. https:\/\/doi.org\/10.1016\/j.trsl.2021.09.001 (2022).","journal-title":"Transl. Res."},{"issue":"3","key":"92304_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5578\/tt.20219708","volume":"69","author":"F Y\u0131ld\u0131r\u0131m","year":"2021","unstructured":"Y\u0131ld\u0131r\u0131m, F., Y\u0131ld\u0131z G\u00fclhan, P. & \u015eim\u015fek, M. COVID-19 related acute respiratory distress syndrome: Pathological, radiological and clinical concordance. Tuberk Toraks 69(3), 360\u2013368 (2021).","journal-title":"Tuberk Toraks"},{"issue":"4","key":"92304_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5578\/tt.69770","volume":"68","author":"GP Y\u0131ld\u0131z","year":"2020","unstructured":"Y\u0131ld\u0131z, G. P. The role of mesenchymal stem cells in COVID-19 treatment. Tuberk Toraks 68(4), 430\u2013436 (2020).","journal-title":"Tuberk Toraks"},{"issue":"3","key":"92304_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jmv.27362","volume":"94","author":"P Yildiz Gulhan","year":"2022","unstructured":"Yildiz Gulhan, P. et al. The evaluation of both the expression and serum protein levels of Caspase-3 gene in patients with different degrees of SARS-CoV2 infection. J Med. Virol. 94(3), 897\u2013905 (2022).","journal-title":"J Med. Virol."},{"issue":"12","key":"92304_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14961","volume":"75","author":"M Acat","year":"2021","unstructured":"Acat, M., Yildiz Gulhan, P., Oner, S. & Turan, M. K. Comparison of pirfenidone and corticosteroid treatments at the COVID-19 pneumonia with the guide of artificial intelligence supported thoracic computed tomography. Int. J. Clin. Pract. 75(12), e14961 (2021).","journal-title":"Int. J. Clin. Pract."},{"issue":"8","key":"92304_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George, P. M., Wells, A. U. & Jenkins, R. G. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir. Med. 8(8), 807\u2013815. https:\/\/doi.org\/10.1016\/S2213-2600(20)30225-3 (2020).","journal-title":"Lancet Respir. Med."},{"issue":"2020","key":"92304_CR7","doi-asserted-by":"publisher","first-page":"6175964","DOI":"10.1155\/2020\/6175964","volume":"10","author":"AS Ojo","year":"2020","unstructured":"Ojo, A. S., Balogun, S. A., Williams, O. T. & Ojo, O. S. Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulm. Med. 10(2020), 6175964. https:\/\/doi.org\/10.1155\/2020\/6175964 (2020).","journal-title":"Pulm. Med."},{"issue":"3","key":"92304_CR8","volume":"14","author":"A Mohammadi","year":"2022","unstructured":"Mohammadi, A. et al. Post-COVID-19 pulmonary fibrosis. Cureus. 14(3), e22770 (2022).","journal-title":"Cureus."},{"key":"92304_CR9","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/2047487320932695","volume":"27","author":"F Gentile","year":"2020","unstructured":"Gentile, F. et al. COVID-19 and risk of pulmonary fibrosis: The importance of planning ahead. Eur. J. Prev. Cardiol. 27, 1442\u20131446 (2020).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"92304_CR10","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz, B. et al. The myofibroblast: One function, multiple origins. Am. J. Pathol. 170, 1807\u20131816 (2007).","journal-title":"Am. J. Pathol."},{"issue":"5","key":"92304_CR11","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","volume":"166","author":"BC Willis","year":"2005","unstructured":"Willis, B. C. et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: Potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166(5), 1321\u20131332 (2005).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"92304_CR12","doi-asserted-by":"publisher","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","volume":"293","author":"BC Willis","year":"2007","unstructured":"Willis, B. C. & Borok, Z. TGF-beta-induced EMT: Mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293(3), L525\u2013L534 (2007).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"9","key":"92304_CR13","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1111\/jcmm.13725","volume":"22","author":"W Qian","year":"2018","unstructured":"Qian, W., Cai, X., Qian, Q., Zhang, W. & Wang, D. Astragaloside IV modulates TGF-\u03b21-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J. Cell. Mol. Med. 22(9), 4354\u20134365 (2018).","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"92304_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jcp.21635","volume":"218","author":"MR Schneider","year":"2009","unstructured":"Schneider, M. R. & Wolf, E. The epidermal growth factor receptor ligands at a glance. J. Cell. Physiol. 218(3), 460\u2013466 (2009).","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"92304_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5578\/kvj.24183","volume":"9","author":"F Kazak","year":"2016","unstructured":"Kazak, F. & Yar\u0131m, F. G. Epidermal B\u00fcy\u00fcme Fakt\u00f6r\u00fc. Kocatepe Vet J. 9(3), 215\u2013225 (2016).","journal-title":"Kocatepe Vet J."},{"issue":"3","key":"92304_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1667\/RR13625.1","volume":"182","author":"EJ Chung","year":"2014","unstructured":"Chung, E. J. et al. Transforming growth factor alpha is a critical mediator of radiation lung injury. Radiat. Res. 182(3), 350\u2013362 (2014).","journal-title":"Radiat. Res."},{"issue":"1","key":"92304_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1074\/jbc.M115.694281","volume":"291","author":"X Yan","year":"2016","unstructured":"Yan, X. et al. Smad7 protein interacts with receptor-regulated smads (R-Smads) to inhibit transforming growth factor-\u03b2 (TGF-\u03b2)\/smad signaling. J. Biol. Chem. 291(1), 382\u2013392 (2016).","journal-title":"J. Biol. Chem."},{"issue":"22","key":"92304_CR18","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.1158\/0008-5472.CAN-11-1330","volume":"71","author":"X Jin","year":"2011","unstructured":"Jin, X. et al. EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction. Cancer Res. 71(22), 7125\u20137134 (2011).","journal-title":"Cancer Res."},{"issue":"18","key":"92304_CR19","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. China medical treatment expert group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382(18), 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"92304_CR20","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jmv.26444","volume":"93","author":"Z Tao","year":"2021","unstructured":"Tao, Z. et al. Anemia is associated with severe illness in COVID-19: A retrospective cohort study. J. Med. Virol. 93(3), 1478\u20131488 (2021).","journal-title":"J. Med. Virol."},{"issue":"1","key":"92304_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","volume":"5","author":"L Tan","year":"2020","unstructured":"Tan, L. et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct. Target Ther. 5(1), 33 (2020).","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"92304_CR22","first-page":"3404","volume":"24","author":"F Zheng","year":"2020","unstructured":"Zheng, F. et al. Clinical characteristics of 161 cases of coronavirus disease 2019 (COVID-19) in Changsha. Eur. Rev. Med. Pharmacol. Sci. 24(6), 3404\u20133410 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"92304_CR23","doi-asserted-by":"crossref","unstructured":"Niu, Y., Zhan, Z. & Li, J., et al. Development of a predictive model for mortality in hospitalized patients with COVID\u201019 [published online ahead of print, 2021 Jan 8]. Disaster Med Public Health Prep. 1\u20139 (2021).","DOI":"10.1017\/dmp.2021.8"},{"issue":"6","key":"92304_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/CRD.0000000000000330","volume":"28","author":"S Shah","year":"2020","unstructured":"Shah, S. et al. Elevated D-Dimer levels are associated with increased risk of mortality in coronavirus disease 2019: a systematic review and meta-analysis. Cardiol. Rev. 28(6), 295\u2013302 (2020).","journal-title":"Cardiol. Rev."},{"issue":"6","key":"92304_CR25","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.dsx.2020.11.007","volume":"14","author":"M Soni","year":"2020","unstructured":"Soni, M., Gopalakrishnan, R., Vaishya, R. & Prabu, P. D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes Metab. Syndr. 14(6), 2245\u20132249 (2020).","journal-title":"Diabetes Metab. Syndr."},{"key":"92304_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajem.2020.12.023","volume":"40","author":"M Ozen","year":"2021","unstructured":"Ozen, M. et al. D-Dimer as a potential biomarker for disease severity in COVID-19. Am. J. Emerg. Med. 40, 55\u201359 (2021).","journal-title":"Am. J. Emerg. Med."},{"key":"92304_CR27","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.926178","volume":"26","author":"C Zhou","year":"2020","unstructured":"Zhou, C., Chen, Y., Ji, Y., He, X. & Xue, D. Increased serum levels of hepcidin and Ferritin are associated with severity of COVID-19. Med. Sci. Monit. 26, e926178 (2020).","journal-title":"Med. Sci. Monit."},{"issue":"7","key":"92304_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.medcle.2020.11.015","volume":"156","author":"F Deng","year":"2021","unstructured":"Deng, F. et al. Increased levels of Ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med. Clin. (Engl. Ed). 156(7), 324\u2013331. https:\/\/doi.org\/10.1016\/j.medcle.2020.11.015 (2021).","journal-title":"Med. Clin. (Engl. Ed)."},{"key":"92304_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1183\/09031936.00015612","volume":"42","author":"BD Uhal","year":"2013","unstructured":"Uhal, B. D. et al. Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis. Eur. Respir. J. 42, 198\u2013210. https:\/\/doi.org\/10.1183\/09031936.00015612 (2013).","journal-title":"Eur. Respir. J."},{"key":"92304_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki, K., Fujiogi, M. & Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clin. Immunol. 215, 108427. https:\/\/doi.org\/10.1016\/j.clim.2020.108427 (2020).","journal-title":"Clin. Immunol."},{"key":"92304_CR31","doi-asserted-by":"publisher","first-page":"L257","DOI":"10.1152\/ajplung.00238.2020","volume":"320","author":"LT McDonald","year":"2021","unstructured":"McDonald, L. T. Healing after COVID-19: Are survivors at risk for pulmonary fibrosis?. Am. J. Physiol. Lung Cell. Mol. Physiol. 320, L257\u2013L265 (2021).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"92304_CR32","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1172\/JCI117251","volume":"93","author":"S Kagami","year":"1994","unstructured":"Kagami, S., Border, W. A., Miller, D. E. & Noble, N. A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Investig. 93, 2431\u20132437 (1994).","journal-title":"J. Clin. Investig."},{"issue":"11","key":"92304_CR33","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s11010-023-04674-7","volume":"478","author":"S Zivancevic-Simonovic","year":"2023","unstructured":"Zivancevic-Simonovic, S. et al. Transforming growth factor beta 1 (TGF-\u03b21) in COVID-19 patients: Relation to platelets and association with the disease outcome. Mol. Cell. Biochem. 478(11), 2461\u20132471 (2023).","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"92304_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/ijms23010168","volume":"23","author":"CB VazdePaula","year":"2021","unstructured":"VazdePaula, C. B. et al. COVID-19: Immunohistochemical analysis of TGF-\u03b2 signaling pathways in pulmonary fibrosis. Int. J. Mol. Sci. 23(1), 168 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"92304_CR35","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1080\/21645515.2020.1799669","volume":"16","author":"M Rokni","year":"2020","unstructured":"Rokni, M., Hamblin, M. R. & Rezaei, N. Cytokines and COVID-19: Friends or foes?. Hum. Vaccin. Immunother. 16(10), 2363\u20132365 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"92304_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107364","volume":"93","author":"L Mohamed Khosroshahi","year":"2021","unstructured":"Mohamed Khosroshahi, L., Rokni, M., Mokhtari, T. & Noorbakhsh, F. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. Int. Immunopharmacol. 93, 107364 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"92304_CR37","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s11033-023-08244-4","volume":"50","author":"M Acat","year":"2023","unstructured":"Acat, M. et al. Evaluation of both expression and serum protein levels of caspase-8 and mitogen-activated protein kinase 1 genes in patients with different severities of COVID-19 infection. Mol. Biol. Rep. 50(4), 3241\u20133248 (2023).","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"92304_CR38","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/jmv.27477","volume":"94","author":"M Heidari Nia","year":"2022","unstructured":"Heidari Nia, M. et al. Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: A case-control study and in silico analyses. J. Med. Virol. 94(4), 1502\u20131512 (2022).","journal-title":"J. Med. Virol."},{"issue":"7","key":"92304_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/cbin.11807","volume":"46","author":"M Rokni","year":"2022","unstructured":"Rokni, M. et al. Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID-19 risk and severity in an Iranian population. Cell. Biol. Int. 46(7), 1109\u20131127 (2022).","journal-title":"Cell. Biol. Int."},{"issue":"1","key":"92304_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-022-02787-w","volume":"24","author":"M Rokni","year":"2022","unstructured":"Rokni, M. et al. The role of endothelin and RAS\/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications. Arthritis Res. Ther. 24(1), 108 (2022).","journal-title":"Arthritis Res. Ther."},{"issue":"55","key":"92304_CR41","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0615-2021","volume":"25","author":"E Laloglu","year":"2022","unstructured":"Laloglu, E. & Alay, H. Role of transforming growth factor-beta 1 and connective tissue growth factor levels in coronavirus disease-2019-related lung Injury: A prospective, observational, cohort study. Rev. Soc. Bras. Med. Trop. 25(55), e06152021 (2022).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"92304_CR42","doi-asserted-by":"publisher","first-page":"117727192211354","DOI":"10.1177\/11772719221135443","volume":"17","author":"H Karadeniz","year":"2022","unstructured":"Karadeniz, H. et al. The prognostic value of lung injury and fibrosis markers, KL-6, TGF-beta1, FGF-2 in COVID-19 patients. Biomark. Insights 17, 11772719221135444 (2022).","journal-title":"Biomark. Insights"},{"key":"92304_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155323","volume":"137","author":"A Ghazavi","year":"2021","unstructured":"Ghazavi, A., Ganji, A., Keshavarzian, N., Rabiemajd, S. & Mosayebi, G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 137, 155323 (2021).","journal-title":"Cytokine."},{"key":"92304_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/rr169","volume":"3","author":"TJ Desai","year":"2002","unstructured":"Desai, T. J. & Cardoso, W. V. Growth factors in lung development and disease: Friends or foe?. Respir. Res. 3, 2 (2002).","journal-title":"Respir. Res."},{"key":"92304_CR45","doi-asserted-by":"publisher","first-page":"L17","DOI":"10.1152\/ajplung.1994.266.1.L17","volume":"266","author":"RM Ryan","year":"1994","unstructured":"Ryan, R. M., Mineo-Kuhn, M. M., Kramer, C. M. & Finkelstein, J. N. Growth factors alter neonatal type II alveolar epithelial cell proliferation. Am. J. Physiol. 266, L17\u2013L22. https:\/\/doi.org\/10.1152\/ajplung.1994.266.1.L17 (1994).","journal-title":"Am. J. Physiol."},{"issue":"1004\u20131010","key":"92304_CR46","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1152\/jappl.1998.85.3.1004","volume":"85","author":"JI Sznajder","year":"1985","unstructured":"Sznajder, J. I., Ridge, K. M., Yeates, D. B., Ilekis, J. & Olivera, W. Epidermal growth factor increases lung liquid clearance in rat lungs. J. Appl. Physiol. 85(1004\u20131010), 1998. https:\/\/doi.org\/10.1152\/jappl.1998.85.3.1004 (1985).","journal-title":"J. Appl. Physiol."},{"key":"92304_CR47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1183\/09031936.00091308","volume":"33","author":"CC Sheu","year":"2009","unstructured":"Sheu, C. C. et al. Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome. Eur. Respir. J. 33, 543\u2013550. https:\/\/doi.org\/10.1183\/09031936.00091308 (2009).","journal-title":"Eur. Respir. J."},{"key":"92304_CR48","doi-asserted-by":"publisher","first-page":"1151246","DOI":"10.3389\/fimmu.2023.1151246","volume":"14","author":"M Sadeghi Shaker","year":"2023","unstructured":"Sadeghi Shaker, M., Rokni, M., Mahmoudi, M. & Farhadi, E. Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases. Front. Immunol. 14, 1151246 (2023).","journal-title":"Front. Immunol."},{"issue":"3","key":"92304_CR49","doi-asserted-by":"publisher","first-page":"R250","DOI":"10.1152\/ajpregu.00324.2020","volume":"320","author":"J Balnis","year":"2021","unstructured":"Balnis, J. et al. Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality. Am. J. Physiol. Regul. Integr. Comp. Physiol. 320(3), R250\u2013R257 (2021).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"92304_CR50","first-page":"719","volume":"10","author":"M Petrushevska","year":"2021","unstructured":"Petrushevska, M., Zendelovska, D., Atanasovska, E., Eftimov, A. & Spasovska, K. Presentation of cytokine profile in relation to oxidative stress parameters in patients with severe COVID-19: A case-control pilot study. F1000Res 10, 719 (2021).","journal-title":"F1000Res"},{"issue":"1","key":"92304_CR51","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1186\/s12889-021-11111-1","volume":"21","author":"I Ayouni","year":"2021","unstructured":"Ayouni, I. et al. Effective public health measures to mitigate the spread of COVID-19: A systematic review. BMC Public Health 21(1), 1015. https:\/\/doi.org\/10.1186\/s12889-021-11111-1 (2021).","journal-title":"BMC Public Health"},{"issue":"1","key":"92304_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000723","volume":"3","author":"JVA Franco","year":"2024","unstructured":"Franco, J. V. A. et al. Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies. BMJ Med. 3(1), e000723 (2024).","journal-title":"BMJ Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92304-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92304-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:07:59Z","timestamp":1742774879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92304-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92304"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92304-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ministry of Health and Local Ethics Committee (D\u00fczce University Local Ethic Committee, Date\/Number 11.05.2020\/89).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients have signed the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"9771"}}